Skip to main content

Utilization of Beta Blockers in the Pediatric Population: A Follow Up Updated Descriptive Analysis

Basic Details
Date Posted
Status
Complete
Medical Product
beta blockers
Description

In this report, we examined and characterized new users of the six most commonly utilized beta blockers among the pediatric population in the Sentinel Distributed Database (SDD). This report is a follow up analysis of two requests, see here and here.

The study period includes data from January 1, 2008 to February 28, 2023. We distributed this request to five Sentinel Data Partners on August 21, 2023.

Deliverables (1)
Sentinel Modular Program Report: Utilization of Beta Blockers in the Pediatric Population: A Follow Up Updated Descriptive Analysis
Additional Details
FDA Center
CDER
Time Period
January 1, 2008 - February 28, 2023
Analysis Type
Descriptive
Population / Cohort
Individuals 0 to 17 years of age
Data Sources
Sentinel Distributed Database (SDD)
Related Links
Sentinel Drug Analysis: Utilization of Beta Blockers in the Pediatric Population: A Descriptive Analysis
Sentinel Drug Analysis: Utilization of Beta Blockers in the Pediatric Population: An Updated Descriptive Analysis
Presentation: Utilization of Beta-blockers Among the Pediatric Population in the United States: A Study in the FDA’s Sentinel System from 2008 to 2022
Presentation: Beta-Blocker-Associated Hypoglycemia in Pediatric Patients: Findings from the FDA Adverse Event Reporting System, National Poison Data System, Medical Literature, and Sentinel Distributed Database